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Purpose: Nerve growth factor (NGF) plays an important role in promoting the healing of corneal wounds. However, the
molecular  mechanism  by  which  NGF  functions  is  unknown.  We  investigated  the  possible  effects  of  NGF  on
phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) and mitogen activated protein kinase (MAPK)/extracellular
signal-regulated kinase (Erk) pathways and cell growth in human corneal epithelial cells (HCECs).
Methods: We examined the effect of NGF on cell cycle and proliferation in HCECs by flow cytometry and cell
proliferation assay, respectively. The levels of D-type cyclins in NGF-treated HCECs were determined by western blot.
The tyrosine kinase A (TrkA), PI3K/Akt and MAPK/Erk pathways were then checked in cells stimulated with NGF for
different time periods or cells undergoing a dose-dependent treatment. Furthermore, HCECs were treated with pathway
inhibitors, LY294002 or PD98059, to confirm NGF-induced activations.
Results: We found that NGF had a positive effect on the growth of HCECs, and D-type cyclins, and it was correlated
with the percentage of the G1 to S progression. We also observed a time-dependent and dose-dependent effect of NGF on
the PI3K/Akt and MAPK/Erk pathways. Furthermore, NGF affected cell cycle progression of HCECs by regulating cyclin
D through Akt and Erk activation upon treatment with the pathway inhibitors, LY294002 for Akt or PD98059 for Erk
pathways.
Conclusions: NGF stimulation could promote cell proliferation and cell cycle progression of HCECs by activation of
cyclin D via the PI3K/Akt and MAPK/Erk signaling pathways.
Nerve growth factor (NGF), which is a well characterized
factor of the neurotrophin family, plays an important role in
growth,  differentiation,  and  survival  of  neurons  [1-4].  A
similar role of NGF is also implicated in the regulation of
corneal biologic functions. Previous studies have shown that
NGF  plays  a  pivotal  role  in  modulating  wound-healing
processes in the cornea [5-10], and in vitro, NGF was found
to  induce  the  proliferation  and  differentiation  of  corneal
epithelium [6]. Furthermore, Qi et al. [11] demonstrated that
NGF  might  support  cell  self-renewal  of  human  corneal
epithelial  progenitor  cells.  However,  the  molecular
mechanisms by which NGF functions in corneal epithelium
are still unclear.
NGF  exerts  its  functions  through  two  membrane
receptors: the tyrosine kinase receptor (TrkA), a high-affinity
receptor of NGF; and the neurotrophin receptor (p75NTR), a
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low-affinity and common receptor for all neurotrophins. NGF
binds to TrkA to induce auto-phosphorylation of the TrkA
receptor,  leading  to  the  activation  of  various  signaling
pathways,  including  phosphatidylinositol  3-kinase  (PI3K)/
protein  kinase  B  (Akt),  mitogen  activated  protein  kinase
(MAPK)/extracellular  signal-regulated  kinase  (Erk)  and
phospholiase C-γ (PLC-γ) [12,13]. The PI3K/Akt and MAPK/
Erk signaling pathways were found to be activated by insulin
in  HCECs  [14],  and  the  insulin-induced  Erk  pathway  is
involved in cell migration in human corneal epithelial cells
(HCECs), leading to corneal wound healing. The PI3K/Akt
signaling pathway is also activated by adenovirus type 19
infection to promote corneal cell survival [15]. Furthermore,
PI3K/Akt as well as MAPK/Erk signaling has been identified
to participate in the epidermal growth factor receptor related
regulation  of  HCEC  proliferation,  migration  [16].  These
studies suggest that the PI3K/Akt and MAPK/Erk signaling
pathways play an important part in regulating corneal biology.
Although NGF has been widely reported to induce Akt and
Erk activity in several types of cells [17-19], there are no
relevant studies in HCECs.
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758Therefore, we investigated the effects of NGF on several
major  signaling  pathways  and  cell  growth  in  HCECs.  To
determine  the  growth  regulatory  mechanism  of  NGF,  we
examined the effect of NGF on the cell cycle in HCECs. We
found that NGF promotes cell growth and G1-S transition by
upregulation of D-type cyclin expression via activation of the
Akt and Erk signaling pathways. Our data suggest that NGF
regulates the cell cycle as an activator of Akt and Erk in
HCECs, and might be a potential therapeutic factor in human
corneal wound healing.
METHODS
Cell culture: The Medical Ethics Committee of Shanghai Eye,
Ear, Nose and Throat (EENT) Hospital approved the study
protocol. The study was conducted in compliance with the
Declaration  of  Helsinki.  As  described  previously  [6],
corneoscleral rims from the donor corneas were obtained from
the eye bank of Shanghai EENT Hospital (Shanghai, China)
as soon as the central corneal button had been used for the
penetrating keratoplasty. The tissue was rinsed with sodium
chloride for three times and then treated with 1.3 unit/ml
Dispase II in defined keratinocyte serum free medium (K-
SFM; GIBCO, Grand Island, NY) at 4 °C for 16 h. The corneal
epithelial sheets were peeled off and digested with 0.05%
trypsin/0.02% EDTA at 37 °C for 10 min to be rendered into
single cells which were then seeded on the 3T3 fibroblasts
feeder layers. The 3T3 fibroblasts were treated with 10 μg/ml
mitomycin C for 2 h and seeded in dishes. The HCECs used
in the whole study was obtained from corneoscleral rims and
cultured  to  passage  one  for  further  studies.  HCECs  were
maintained in the medium composed by 75% K-SFM and 25%
Dulbecco’s  modified  essential  medium  (DMEM)  F-12
(Hyclone; Thermo, Fisher Scientific Inc., Logan, UT), The
DMEM F-12 was supplemented with 10% fetal bovine serum
(GIBCO) and 1% penicillin/streptomysin (Ji Nuo Biologic
Science Co. Ltd, Shanghai, China). The cells used for the
experiments  except  cell  proliferation  assay  or  cell  cycle
analysis were incubated in define K-SFM without growth
factors for 24 h for synchronization. Before harvest for the
analysis, the cells were treated with 0.25% trypsin/0.02%
EDTA at room temperature to remove the 3T3 fibroblasts
feeder layers.
Drug treatment: For drug treatment, cells were incubated in
K-SFM without growth factors for 24 h for synchronization,
and then treated for the indicated concentration and period.
Drugs were used as follows: human recombinant NGF-β from
Sigma-Aldrich (St. Louis, MO), diluted in PBS containing
0.1%  BSA;  the  PI3K/Akt  inhibitor  LY294002;  and  the
MAPK/ Erk inhibitor PD98059 from Sigma-Aldrich, diluted
in dimethyl sulfoxide.
Immunostaining: HCECs cultured in 6-well plates were fixed
in 95% ethanol for 20 min and then dried at room temperature.
After three rinses with PBS for 5 min each and pre-incubation
with 1% normal rabbit serum to block nonspecific staining,
the  cells  were  then  incubated  with  anti-cytokeratin  12
antibody (1:100) from Santa Cruz Biotechnology (Santa Cruz,
CA) for 1 h. After three washes with PBS for 5 min each, cells
were incubated with a FITC-conjugated secondary antibody
(1:100; Sigma-Aldrich, St. Louis, MO) for 45 min. Cells were
then washed for three additional times, and counterstained
with Hoechst 33342 (10 g/ml). Mounted with a Mowiol 4–88
media  (Sigma-Aldrich),  HCECs  were  analyzed  with  a
fluorescence microscope.
Cell proliferation assay: The CellTiter 96® AQueous One
Solution cell proliferation assay kit (Promega, Madison, WI)
was used for measurement of cell proliferation. As described
by the manufacturer, cells were seeded onto 96-well plates at
the  density  of  6×103  per  well  in  defined  K-SFM  with  or
without  the  recombinant  NGF-β  and  then  incubated  with
20 µl/well CellTiter 96® AQueous One Solution Reagent at
37 °C for 4 h. The absorbance was recorded at 490 nm using
a 96-well plate reader (Bio-Rad, CA).
Cell cycle analysis: Cells were trypsinized, washed once with
ice-cold PBS, and fixed with 75% ethanol at −20 °C overnight.
After washing twice with PBS, cells were stained with 10 µg/
ml propidium iodide (Sigma-Aldrich) containing 1 mg/ml
RNase A (Sigma-Aldrich) at 37 °C for 20 min in the dark and
analyzed with FACSCalibur flow cytometer and CellQuest
software (BD Biosciences, San Diego, CA).
Immunoblotting:  Cells  were  lysed  in
radioimmunoprecipitation assay (RIPA) buffer supplemented
with protease inhibitors (Complete, Mini, EDTA-free; Roche
Applied Science, Indianapolis, IN) and phosphatase inhibitor
cocktails 1 and 2 (Sigma) and centrifuged to get the cleared
lysates. Antibodies against Tyr674/675 phospho-TrkA, total
TABLE 1. RT–PCR PRIMERS.
Gene Direction Primer sequence
cyclin D1 Forward AGCCATGGAACACCAGCTC
  Reverse GCACCTCCAGCATCCAGGT
cyclin D2 Forward TACTTCAAGTGCGTGCAGAAGGAC
  Reverse TCCCACACTTCCAGTTGCGATCAT
GAPDH Forward GCCAAGGTCATCCATGACAAC
  Reverse GTCCACCACCCTGTTGCTGTA
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759TrkA,  Ser473  phospho-Akt,  total  Akt,  Thr202/Tyr204
phospho-p44/42  MAPK  (Erk1/2),  total  p44/42  MAPK
(Erk1/2), cyclin D2, and anti-Rabbit IgG HRP-conjugated
Secondary Antibody were from Cell Signaling Technology
(Beverly, MA). Antibody against cyclin D1 was from Santa
Cruz  Biotechnology  (Santa  Cruz,  CA).  Antibody  against
glyceraldehyde phosphate dehydrogenase (GAPDH) was the
gift from Miao Tong Biologic Science & Technology Co. Ltd
(Shanghai, China).
Reverse transcription-PCR: Total RNA was isolated with
Trizol (Invitrogen, Carlsbad, CA) and reverse transcription-
PCR (RT–PCR) was done with RT–PCR system (TAKARA
Biotechnology, Dalian, China) according to the instructions
of the manufacturers. Amplified cDNAs were then performed
for PCR. The primers used are listed in Table 1.
RESULTS
NGF promotes cell growth of human corneal epithelial cells:
HCECs cultured in vitro displayed a polygonal pattern, and
expressed cytokeratin 12, which is a biomarker for corneal
epithelium  (Figure  1A).  To  explore  the  role  of  NGF  in
HCECs,  we  first  performed  a  cell  proliferation  assay  to
analyze cell growth. As shown in Figure 1B, HCECs were
treated with human recombinant β-NGF in defined K-SMF
with growth factors, and cell growth was promoted by NGF
treatment at 5 ng/ml (p<0.05, Student’s t test). HCECs were
then treated with NGF and the cell cycle was analyzed by flow
Figure 1. Effect of nerve growth factor on cell proliferation and the cell cycle in human corneal epithelial cells. A: Human corneal epithelial
cells (HCECs) cultured in vitro displayed a polygonal pattern (left panel). Immunostaining for cytokeratin 12 (green) followed by Hoechst
staining (blue; right panel) is shown. B: HCECs were seeded onto 96 well plates at a density of 6×103 per well in defined keratinocyte serum-
free medium (K-SFM), and then treated with recombinant nerve growth factor β-NGF at 5 ng/ml and subjected to a cell proliferation assay
for up to 6 days. C: HCECs at passage 1 were plated onto 60-mm dishes. The cell cycle was analyzed by flow cytometry with cells treated
identically at day 4 of the cell proliferation assay (upper panel), and the percentage of each phase (G1-M) is indicated on the right (lower
panel). Experiments were performed in triplicate and statistically analyzed with the Student t test. The results are shown as mean±standard
deviation (SD). All p-values (*) were considered statistically significant when p<0.05.
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760cytometry with cells treated identically as day 4 of the cell
proliferation assay. The percentage of G1 phase cells was
slightly reduced in NGF treated cells, while the S phase cells
were increased (p<0.05, Student’s t test, Figure 1C). Taken
together, these results indicate that NGF accelerated growth
of human corneal epithelial cells through G1 promotion.
NGF  induces  activity  of  the  PI3K/Akt  and  MAPK/Erk
signaling  pathways  in  HCECs:  Since  we  found  that  cell
growth of HCECs was positively regulated by NGF, we then
investigated the mechanism by which NGF enhanced HCEC
proliferation. To determine the optimal conditions of NGF
treatment for the mechanism study, we treated HCECs with
various concentration of NGF and examined at different time
points, and measured the activity of NGF signaling. TrkA, the
high-affinity  receptor  of  NGF,  was  activated  immediately
when cells were stimulated by NGF (Figure 2A). Although
NGF has been shown to regulate several signaling pathways
in other cell lines, it is still unclear whether NGF affects
signaling pathways in HCECs. Therefore, we examined two
important  downstream  signaling  pathways,  PI3K/Akt  and
MAPK/Erk, which play important roles in cell proliferation.
In the time-dependent treatment, phosphorylation levels of
Akt (p-Akt) at Ser473 and Erk1/2 (p-Erk) at Thr202/Tyr204
were increased within 10 min, reached a maximum after 60
min and remained high even after 2 h (Figure 2A). Upon dose-
dependent treatment, NGF caused increased phosphorylation
of the Akt and Erk pathways at a concentration of 5 ng/ml and
a  maximal  effect  was  observed  at  25  ng/ml  (Figure  2B).
However,  the  Akt  and  Erk  pathways  underwent  delayed
activation that lagged behind the phosphorylation of TrkA.
These results indicated that NGF induced the activity of the
Akt and Erk signaling pathways in HCECs, which may require
time for signaling transmission.
NGF  promotes  cell  cycle  progression  via  Akt  and  Erk
activation  in  HCECs:  According  to  our  results  shown  in
Figure 2, we treated HCECs at 25 ng/ml for 1 h and examined
the expression of D-type cyclin, which play crucial roles in
G1 to S transition. We found that both cyclin D1 and cyclin
D2 expression were upregulated by NGF at the protein level
but not the mRNA level in HCECs (Figure 3A). Since we
found that the Akt and Erk pathways were positively regulated
by NGF at the phosphorylation level, we next investigated
whether  there  was  any  correlation  between  the  signaling
pathways and NGF-induced cell growth. We found that the
phosphorylation  of  Erk  was  markedly  repressed  with
treatment with the PI3K/Akt inhibitor LY294002 and MAPK/
Erk  inhibitor  PD98059  (Figure  3B).  LY294002-treated
HCECs  displayed  a  significant  decrease  in  Akt  and  Erk
phosphorylation,  while  PD98059-treated  cells  showed  a
decrease in the Erk phosphorylation, which suggested that Akt
pathway might be the upstream of the Erk pathway after NGF
treatment. Furthermore, both D-type cyclins expressions were
repressed  by  LY294002  or  PD98059  treatment,  which
suggested that cyclin D was the downstream target of the Akt
Figure 2. Effect of nerve growth factor on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) and mitogen activated protein
kinase (MAPK)/extracellular signal-regulated kinase (Erk) signaling pathways in human corneal epithelial cells. A: Human corneal epithelial
cells (HCECs) were incubated in defined keratinocyte serum-free medium (K-SFM) without growth factors for 24 h before nerve growth
factor (NGF) stimulation and then treated with NGF at 25 ng/ml for different periods. B: HCECs were treated with different concentrations
of NGF for 60 min. A total of 50 μg cell lysates were analyzed for expression of the indicated genes by immunoblotting analysis. Tyr674/675
phospho-TrkA indicates the NGF signaling activity. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control.
For both A and B, results are representative of three independent experiments. Experiments were performed in triplicate.
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761and Erk pathways. Therefore, these data showed a positive
effect of NGF on the Akt and Erk pathways, and suggested
that NGF promoted cell cycle progression of HCECs through
the Akt and Erk pathways.
DISCUSSION
In this study, we showed that NGF stimulation might favor
cell cycle progression of human corneal epithelial cells by
activation of cyclin D via the Akt and Erk signaling pathways.
Our  data  also  indicated  that  activation  of  the  Akt  or  Erk
signaling pathway by NGF was time- and dose-dependent.
This positive effect of NGF on cell growth of HCECs was
confirmed by treating cells with inhibitors of these signaling
pathways, namely LY294002 for Akt and PD98059 for Erk.
Previous studies have shown that corneal nerve injury
results in the dysfunction of corneal epithelium and delays its
wound healing [7,20], and NGF is indispensable for corneal
wound  healing.  Autocrine  NGF  levels  of  the  corneal
epithelium are significantly increased in the wounded eye
after 24 h [6]. The wound healing rate is decreased when NGF
is down-regulated by bevacizumab eye drops [21]. After laser-
assisted in situ keratomileusis (LASIK), commonly referred
to as laser eye surgery, which cuts off the corneal nerve,
autocrine NGF levels in tears are decreased [22] and the loss
of  innervation  contributes  to  the  loss  of  keratocytes  after
LASIK  [23].  NGF  eye-drops  can  promote  the  healing  of
corneal  ulcers  [7,24],  and  can  be  a  therapeutic  factor  in
preventig allograft rejection in the cornea. NGF treatment may
restore a deficit in the synthesis or release of endogenous NGF
[25,26].  Therefore,  NGF  might  be  involved  in  sensory
innervation and proliferation and differentiation of epithelial
cells [27]. However, the exact molecular mechanism of the
effect  of  NGF  on  human  corneal  epithelium  is  not  well
defined. Our study revealed that NGF promotes cell cycle
progression by regulating D-type cyclins via Akt activation in
human corneal epithelial cells. It should be pointed out that
HCECs were treated by NGF at 25 ng/ml for 1 h in the current
study for cell growth or cell cycle analysis. This concentration
is different from results of previous report. Bonini et al. found
that  murine  NGF  (100–200  mg/ml)  improved  corneal
sensitivity and promoted corneal epithelial healing in both
moderate and severe neurotrophic keratitis [7]. Kruse et al.
studied two different concentrations of NGF (50 and 250 ng/
ml) and their effects on growth and differentiation of rabbit
limbal epithelium [28]. They found that the colony size of cells
was significantly increased by NGF at the concentrations of
250  ng/ml  compared  with  50  ng/ml.  The  various
concentrations  and  times  of  NGF  treatment  might  be
attributed to the difference between in vivo and in vitro testing,
and different cultured cells (rabbit versus human). Therefore,
Figure 3. Nerve growth factor promotes cell cycle progression via Akt and Erk activation in human corneal epithelial cells. A: Human corneal
epithelial cells (HCECs) were incubated in keratinocyte serum-free medium (K-SFM) without growth factors for 24 h before treatment with
nerve growth factor (NGF) at 25 ng/ml for 1 h. A total of 50 µg cell lysates and total RNA were analyzed for expression of the indicated genes
by  western  blot  analysis  and  reverse  transcriptase–polymerase  chain  reaction  (RT–PCR),  respectively.  Glyceraldehyde  3-phosphate
dehydrogenase (GAPDH) was used as a loading control. B: HCECs were incubated in K-SFM without growth factors for 24 h and then
pretreated with LY294002 or PD98059 at 10 µM for 1 h before treatment with NGF at 25 ng/ml for another hour. A total of 50 μg cell lysates
were analyzed for expression of the indicated genes by immunoblotting analysis. GAPDH was used as a loading control. Experiments were
performed in triplicate. C: The schematic representation depicts how the Akt and Erk pathways collaborate to control NGF induction of cyclin
D expression.
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762the Akt and Erk pathways, which were previously reported to
regulate  cell  growth,  proliferation,  differentiation  and
angiogenesis [29], are also activated by NGF in HCECs.
Cyclin D is a member of the cyclin-dependent kinase
(Cdk) family of serine/threonine kinases, which play a crucial
role in modulating progression through the cell cycle. Cyclin
D1 has been identified to be induced concordant with NGF-
induced neurite outgrowth in PC12 cells [30-32]. Cyclin D2
has also been reported to be positively correlated with NGF
expression  [33-35].  Moreover,  Marampon  et  al.  [31]
suggested that cyclin D1 induction by NGF involves the PI3K/
Akt, Erk and p38 pathways in PC12 cells. However, it is
unknown whether NGF-induced corneal wound healing is
correlated with expression of D-type cyclins. In our study,
NGF promoted cell growth and enhanced cyclin D expression
at the protein level, but not the mRNA level (Figure 3A),
which is different from results in other studies that showed
NGF  stimulates  cyclin  D1  promoter  activity  and  mRNA
synthesis  [30,31].  The  reason  for  this  difference  between
studies might be that the peak time point for protein and
mRNA  level  might  differ.  Cyclin  D1  is  reported  to  be
excluded from the nucleus during the S phase and the protein
is rapidly degraded through phosphorylation by β-glycogen
synthase kinase 3 [36]. Therefore, NGF might play a pivotal
role in inhibiting the degradation of cyclin D by other factors.
It is possible that NGF promotes cell cycle progression of
HCECs through rescuing the expression of cyclin D.
The  PI3K/Akt  signaling  pathway  has  been  shown  to
promote corneal cell survival [15]. MAPK/Erk as well as
PI3K/Akt also play a positive role in HCEC proliferation,
migration and corneal wound healing [14,16]. In addition, our
results of microarray analysis found that D-type cyclins were
involved in the proliferation of HCECs upon NGF treatment.
We  therefore  hypothesize  that  each  of  these  signaling
pathways contribute to NGF induction of cyclin D expression,
and thereby to HCEC proliferation. In the current study, we
shownd that NGF-induced cyclin D protein expression was
strongly  reduced  by  chemical  inhibitors  of  the  PI3K/Akt
(LY294002)  and  MAPK/Erk  (PD098059)  pathways,
suggesting that NGF might regulate cyclin D1 and cyclin D2
expression via Akt and Erk (Figure 3). Upon NGF treatment,
Akt pathway inhibition also reduced the Erk activation status.
However, inhibition of the Erk pathway seemed to have very
little effect on Akt phosphorylation levels, suggesting that the
Erk signaling pathway might be downstream of Akt in the
process of NGF-induced cell proliferation of HCECs (Figure
3B).
In conclusion, our findings demonstrate that activation of
cyclin D via the PI3K/Akt and MAPK/Erk signaling pathways
are involved in the proliferation of corneal epithelial cells
treated  with  NGF.  Further  investigation  is  required  to
determine whether NGF is associated with self-renewal of
corneal  epithelial  stem  cells  at  the  limbus,  and  if  it  is  a
potential regulator of the limbal stem cell niche.
ACKNOWLEDGMENTS
This  work  was  supported  by  grants  from  the  Key  Clinic
Medicine Research Program, the Ministry of Health, China
(2010–2012);  National  Science  and  Technology  Research
Program, the Ministry of Science and Technology, China 
(2012BAI08B01); National Natural Science Foundation of
China  (81020108017,  30872815);  Shanghai  Excellent
Leading  Scholars  Program,  Science  and  Technology
Commission  of  Shanghai  Municipality,  Shanghai
(10XD1401100,  11231200602).  The  sponsor  or  funding
organization had no role in the design or conduct of this
research.
REFERENCES
1. Levi-Montalcini R. The nerve growth factor: its role in growth,
differentiation and function of the sympathetic adrenergic
neuron. Prog Brain Res 1976; 45:235-58. [PMID: 1013339]
2. Greene  LA,  Tischler  AS.  Establishment  of  a  noradrenergic
clonal  line  of  rat  adrenal  pheochromocytoma  cells  which
respond to nerve growth factor. Proc Natl Acad Sci USA
1976; 73:2424-8. [PMID: 1065897]
3. Chao MV. Neurotrophin receptors: a window into neuronal
differentiation. Neuron 1992; 9:583-93. [PMID: 1327010]
4. Shooter EM. Early days of the nerve growth factor proteins.
Annu Rev Neurosci 2001; 24:601-29. [PMID: 11283322]
5. Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F.
Nerve  growth  factor  involvement  in  the  visual  system:
implications  in  allergic  and  neurodegenerative  diseases.
Cytokine  Growth  Factor  Rev  2004;  15:411-7.  [PMID:
15561599]
6. Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L.
Nerve growth factor promotes corneal healing: structural,
biochemical,  and  molecular  analyses  of  rat  and  human
corneas. Invest Ophthalmol Vis Sci 2000; 41:1063-9. [PMID:
10752942]
7. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical
treatment with nerve growth factor for neurotrophic keratitis.
Ophthalmology 2000; 107:1347-51. [PMID: 10889110]
8. Lambiase A, Bonini S, Micera A, Rama P, Aloe L. Expression
of nerve growth factor receptors on the ocular surface in
healthy subjects and during manifestation of inflammatory
diseases.  Invest  Ophthalmol  Vis  Sci  1998;  39:1272-5.
[PMID: 9620090]
9. Baum J. Topical treatment with nerve growth factor for corneal
neurotrophic  ulcers.  Surv  Ophthalmol  1999;  43:372-3.
[PMID: 10025520]
10. Esquenazi S, Bazan HE, Bui V, He J, Kim DB, Bazan NG.
Topical  combination  of  NGF  and  DHA  increases  rabbit
corneal nerve regeneration after photorefractive keratectomy.
Invest  Ophthalmol  Vis  Sci  2005;  46:3121-7.  [PMID:
16123410]
11. Qi  H,  Li  DQ,  Shine  HD,  Chen  Z,  Yoon  KC,  Jones  DB,
Pflugfelder SC. Nerve growth factor and its receptor TrkA
serve  as  potential  markers  for  human  corneal  epithelial
progenitor  cells.  Exp  Eye  Res  2008;  86:34-40.  [PMID:
17980361]
Molecular Vision 2012; 18:758-764 <http://www.molvis.org/molvis/v18/a81> © 2012 Molecular Vision
76312. Caporali  A,  Emanueli  C.  Cardiovascular  actions  of
neurotrophins.  Physiol  Rev  2009;  89:279-308.  [PMID:
19126759]
13. Reichardt  LF.  Neurotrophin-regulated  signalling  pathways.
Philos Trans R Soc Lond B Biol Sci 2006; 361:1545-64.
[PMID: 16939974]
14. Shanley LJ, McCaig CD, Forrester JV, Zhao M. Insulin, not
leptin, promotes in vitro cell migration to heal monolayer
wounds in human corneal epithelium. Invest Ophthalmol Vis
Sci 2004; 45:1088-94. [PMID: 15037573]
15. Rajala MS, Rajala RV, Astley RA, Butt AL, Chodosh J. Corneal
cell  survival  in  adenovirus  type  19  infection  requires
phosphoinositide  3-kinase/Akt  activation.  J  Virol  2005;
79:12332-41. [PMID: 16160160]
16. Yang H, Wang Z, Capo-Aponte JE, Zhang F, Pan Z, Reinach
PS. Epidermal growth factor receptor transactivation by the
cannabinoid receptor (CB1) and transient receptor potential
vanilloid 1 (TRPV1) induces differential responses in corneal
epithelial  cells.  Exp  Eye  Res  2010;  91:462-71.  [PMID:
20619260]
17. Romon  R,  Adriaenssens  E,  Lagadec  C,  Germain  E,
Hondermarck H, Le Bourhis X. Nerve growth factor promotes
breast cancer angiogenesis by activating multiple pathways.
Mol Cancer 2010; 9:157. [PMID: 20569463]
18. Barouch R, Kazimirsky G, Appel E, Brodie C. Nerve growth
factor  regulates  TNF-alpha  production  in  mouse
macrophages via MAP kinase activation. J Leukoc Biol 2001;
69:1019-26. [PMID: 11404390]
19. Obermeier A, Ahmed S, Manser E, Yen SC, Hall C, Lim L.
PAK promotes morphological changes by acting upstream of
Rac. EMBO J 1998; 17:4328-39. [PMID: 9687501]
20. Hamrah P, Cruzat A, Dastjerdi MH, Zheng L, Shahatit BM,
Bayhan HA, Dana R, Pavan-Langston D. Corneal sensation
and subbasal nerve alterations in patients with herpes simplex
keratitis:  an  in  vivo  confocal  microscopy  study.
Ophthalmology 2010; 117:1930-6. [PMID: 20810171]
21. Kim  EC,  Lee  WS,  Kim  MS.  The  inhibitory  effects  of
bevacizumab  eye  drops  on  NGF  expression  and  corneal
wound  healing  in  rats.  Invest  Ophthalmol  Vis  Sci  2010;
51:4569-73. [PMID: 20393106]
22. Tang YCR. Relationship between the levels of nerve growth
factor in tears and tear film stability after LASIK. Chinese
Journal of Modern Eye Ear Nose and Throat 2007:1681–
6412(2007)01–0014–03.
23. Lee  BH,  McLaren  JW,  Erie  JC,  Hodge  DO,  Bourne  WM.
Reinnervation in the cornea after LASIK. Invest Ophthalmol
Vis Sci 2002; 43:3660-4. [PMID: 12454033]
24. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical
treatment with nerve growth factor for corneal neurotrophic
ulcers. N Engl J Med 1998; 338:1174-80. [PMID: 9554857]
25. Brewster  WJ,  Fernyhough  P,  Diemel  LT,  Mohiuddin  L,
Tomlinson DR. Diabetic neuropathy, nerve growth factor and
other neurotrophic factors. Trends Neurosci 1994; 17:321-5.
[PMID: 7974749]
26. Anand P, Pandya S, Ladiwala U, Singhal B, Sinicropi DV,
Williams-Chestnut RE. Depletion of nerve growth factor in
leprosy. Lancet 1994; 344:129-30. [PMID: 7912365]
27. Anand P. Nerve growth factor regulates nociception in human
health and disease. Br J Anaesth 1995; 75:201-8. [PMID:
7577254]
28. Kruse FE, Tseng SC. Growth factors modulate clonal growth
and  differentiation  of  cultured  rabbit  limbal  and  corneal
epithelium. Invest Ophthalmol Vis Sci 1993; 34:1963-76.
[PMID: 8491549]
29. Cantley LC. The phosphoinositide 3-kinase pathway. Science
2002; 296:1655-7. [PMID: 12040186]
30. Yan GZ, Ziff EB. Nerve growth factor induces transcription of
the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by
activating  the  Sp1  transcription  factor.  J  Neurosci  1997;
17:6122-32. [PMID: 9236224]
31. Marampon F, Casimiro MC, Fu M, Powell MJ, Popov VM,
Lindsay  J,  Zani  BM,  Ciccarelli  C,  Watanabe  G,  Lee  RJ,
Pestell RG. Nerve Growth factor regulation of cyclin D1 in
PC12 cells through a p21RAS extracellular signal-regulated
kinase  pathway  requires  cooperative  interactions  between
Sp1  and  nuclear  factor-kappaB.  Mol  Biol  Cell  2008;
19:2566-78. [PMID: 18367547]
32. Nguyen TX, Ahn JY. Lipase inactive mutant of PLC-gamma1
regulates  NGF-induced  neurite  outgrowth  via  enzymatic
activity and regulation of cell cycle regulatory proteins. J
Biochem Mol Biol 2007; 40:888-94. [PMID: 18047783]
33. Kerr B, Garcia-Rudaz C, Dorfman M, Paredes A, Ojeda SR.
NTRK1 and NTRK2 receptors facilitate follicle assembly and
early  follicular  development  in  the  mouse  ovary.
Reproduction 2009; 138:131-40. [PMID: 19357131]
34. Tamaru T, Okada M, Nakagawa H. Differential expression of
D type cyclins during neuronal maturation. Neurosci Lett
1994; 168:229-32. [PMID: 8028782]
35. Zhao ZK, Jiang ZM, Liu XZ, Chen YT, Jia WJ. Study on
reversion  of  malignant  phenotype  of  glioma  by  siRNA
targeting p75 neurotrophin receptor. Zhonghua Bing Li Xue
Za Zhi 2010; 39:400-4. [PMID: 21055158]
36. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative
regulators  of  G1-phase  progression.  Genes  Dev  1999;
13:1501-12. [PMID: 10385618]
Molecular Vision 2012; 18:758-764 <http://www.molvis.org/molvis/v18/a81> © 2012 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 27 March 2012. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
764